AI-powered care coordination platform for disease detection and workflow optimization, powered by 50+ FDA-cleared AI algorithms. Trusted by over 2,000 hospitals.
Contact Viz.ai for current plans, volume pricing, and enterprise terms.
Trust profile
Viz.ai announced it will provide its Viz Neuro Suite, including Viz ICH and Viz ICH Plus, to support the multicenter MINUTE trial. The study evaluates the SCUBA technique—an endoscopic, catheter-based approach for the evacuation of basal ganglia intracerebral hemorrhage. Viz.ai's platform will be used at participating trial sites to facilitate rapid patient identification and care coordination, aiming to assist clinical teams in meeting the study's ultra-early intervention protocol of within 120 minutes of key clinical time points.
Viz.ai has entered a partnership with Cortechs.ai to integrate NeuroQuant and NeuroQuant MS software into the Viz platform. This initiative marks Viz.ai’s formal expansion into neurodegenerative disease, beginning with multiple sclerosis (MS) care. By incorporating quantitative MRI analysis directly into its care coordination workflow, the company aims to help clinicians improve the identification and management of patients with MS and other neurodegenerative conditions across its U.S. hospital network.